GENEVA (AP) — Swiss biotech company Roche says sales grew 5 percent in the first nine months of the year, crediting new product launches and citing double-digit growth in the pharmaceuticals division in the U.S. market. The Basel-based drugs and diagnostics group expressed confidence about meeting full-year targets and pointed to recent regulatory approvals in the European Union. Overall, sales rose to 39.4 billion Swiss francs ($40.2 billion) in the period, from 37.5 billion a year earlier.

Topics:  geneva ap     swiss   roche   the basel-based   european   union   swiss   u.s    group   sales   billion   percent   year   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News